Cationized ferritin as a magnetic resonance imaging probe to detect microstructural changes in a rat model of non-alcoholic steatohepatitis

Scott C. Beeman, Lawrence J. Mandarino, Joseph F. Georges, Kevin M. Bennett

    Research output: Contribution to journalArticle

    8 Citations (Scopus)

    Abstract

    Purpose The goal of this work was to detect disease-related microstructural changes to the liver using magnetic resonance imaging. Chronic liver disease can cause microstructural changes in the liver that reduce plasma access to the perisinusoidal space - the site of exchange between the blood plasma and the hepatic parenchyma. The reduced plasma access to the perisinusoidal space inhibits hepatic function and contributes to the ∼30,000 chronic liver disease-related deaths per year. Methods The extracellular matrix-specific cationized ferritin magnetic resonance imaging probe was injected intravenously into healthy rats and a rat model of the chronic liver disease non-alcoholic steatohepatitis. Rats were subsequently imaged with T2*-weighted magnetic resonance imaging. Results This work demonstrates that the binding of cationized ferritin to the perisinusoidal extracellular matrix is reduced by 55% in a rat model of non-alcoholic steatohepatitis compared to healthy controls. This reduced binding is detectable in vivo with magnetic resonance imaging. Immunofluorescence and electron microscopy indicated that the reduced binding is due to inhibited macromolecular access to the perisinusoidal space caused by non-alcoholic steatohepatitis-related microstructural changes. Conclusions The reduced accumulation of intravenously injected cationized ferritin may report on changes in macromolecular access to the liver parenchyma in chronic liver disease. Magn Reson Med 70:1728-1738, 2013. © 2013 Wiley Periodicals, Inc.

    Original languageEnglish (US)
    Pages (from-to)1728-1738
    Number of pages11
    JournalMagnetic Resonance in Medicine
    Volume70
    Issue number6
    DOIs
    StatePublished - Dec 2013

    Fingerprint

    Fatty Liver
    Magnetic Resonance Imaging
    Liver Diseases
    Chronic Disease
    Liver
    Extracellular Matrix
    Fluorescence Microscopy
    Electron Microscopy
    polycationic ferritin

    Keywords

    • chronic liver disease
    • magnetic resonance imaging
    • molecular imaging
    • NASH

    ASJC Scopus subject areas

    • Radiology Nuclear Medicine and imaging

    Cite this

    Cationized ferritin as a magnetic resonance imaging probe to detect microstructural changes in a rat model of non-alcoholic steatohepatitis. / Beeman, Scott C.; Mandarino, Lawrence J.; Georges, Joseph F.; Bennett, Kevin M.

    In: Magnetic Resonance in Medicine, Vol. 70, No. 6, 12.2013, p. 1728-1738.

    Research output: Contribution to journalArticle

    Beeman, Scott C. ; Mandarino, Lawrence J. ; Georges, Joseph F. ; Bennett, Kevin M. / Cationized ferritin as a magnetic resonance imaging probe to detect microstructural changes in a rat model of non-alcoholic steatohepatitis. In: Magnetic Resonance in Medicine. 2013 ; Vol. 70, No. 6. pp. 1728-1738.
    @article{bc8050039f0a46d78df734b05e121f2b,
    title = "Cationized ferritin as a magnetic resonance imaging probe to detect microstructural changes in a rat model of non-alcoholic steatohepatitis",
    abstract = "Purpose The goal of this work was to detect disease-related microstructural changes to the liver using magnetic resonance imaging. Chronic liver disease can cause microstructural changes in the liver that reduce plasma access to the perisinusoidal space - the site of exchange between the blood plasma and the hepatic parenchyma. The reduced plasma access to the perisinusoidal space inhibits hepatic function and contributes to the ∼30,000 chronic liver disease-related deaths per year. Methods The extracellular matrix-specific cationized ferritin magnetic resonance imaging probe was injected intravenously into healthy rats and a rat model of the chronic liver disease non-alcoholic steatohepatitis. Rats were subsequently imaged with T2*-weighted magnetic resonance imaging. Results This work demonstrates that the binding of cationized ferritin to the perisinusoidal extracellular matrix is reduced by 55{\%} in a rat model of non-alcoholic steatohepatitis compared to healthy controls. This reduced binding is detectable in vivo with magnetic resonance imaging. Immunofluorescence and electron microscopy indicated that the reduced binding is due to inhibited macromolecular access to the perisinusoidal space caused by non-alcoholic steatohepatitis-related microstructural changes. Conclusions The reduced accumulation of intravenously injected cationized ferritin may report on changes in macromolecular access to the liver parenchyma in chronic liver disease. Magn Reson Med 70:1728-1738, 2013. {\circledC} 2013 Wiley Periodicals, Inc.",
    keywords = "chronic liver disease, magnetic resonance imaging, molecular imaging, NASH",
    author = "Beeman, {Scott C.} and Mandarino, {Lawrence J.} and Georges, {Joseph F.} and Bennett, {Kevin M.}",
    year = "2013",
    month = "12",
    doi = "10.1002/mrm.24619",
    language = "English (US)",
    volume = "70",
    pages = "1728--1738",
    journal = "Magnetic Resonance in Medicine",
    issn = "0740-3194",
    publisher = "John Wiley and Sons Inc.",
    number = "6",

    }

    TY - JOUR

    T1 - Cationized ferritin as a magnetic resonance imaging probe to detect microstructural changes in a rat model of non-alcoholic steatohepatitis

    AU - Beeman, Scott C.

    AU - Mandarino, Lawrence J.

    AU - Georges, Joseph F.

    AU - Bennett, Kevin M.

    PY - 2013/12

    Y1 - 2013/12

    N2 - Purpose The goal of this work was to detect disease-related microstructural changes to the liver using magnetic resonance imaging. Chronic liver disease can cause microstructural changes in the liver that reduce plasma access to the perisinusoidal space - the site of exchange between the blood plasma and the hepatic parenchyma. The reduced plasma access to the perisinusoidal space inhibits hepatic function and contributes to the ∼30,000 chronic liver disease-related deaths per year. Methods The extracellular matrix-specific cationized ferritin magnetic resonance imaging probe was injected intravenously into healthy rats and a rat model of the chronic liver disease non-alcoholic steatohepatitis. Rats were subsequently imaged with T2*-weighted magnetic resonance imaging. Results This work demonstrates that the binding of cationized ferritin to the perisinusoidal extracellular matrix is reduced by 55% in a rat model of non-alcoholic steatohepatitis compared to healthy controls. This reduced binding is detectable in vivo with magnetic resonance imaging. Immunofluorescence and electron microscopy indicated that the reduced binding is due to inhibited macromolecular access to the perisinusoidal space caused by non-alcoholic steatohepatitis-related microstructural changes. Conclusions The reduced accumulation of intravenously injected cationized ferritin may report on changes in macromolecular access to the liver parenchyma in chronic liver disease. Magn Reson Med 70:1728-1738, 2013. © 2013 Wiley Periodicals, Inc.

    AB - Purpose The goal of this work was to detect disease-related microstructural changes to the liver using magnetic resonance imaging. Chronic liver disease can cause microstructural changes in the liver that reduce plasma access to the perisinusoidal space - the site of exchange between the blood plasma and the hepatic parenchyma. The reduced plasma access to the perisinusoidal space inhibits hepatic function and contributes to the ∼30,000 chronic liver disease-related deaths per year. Methods The extracellular matrix-specific cationized ferritin magnetic resonance imaging probe was injected intravenously into healthy rats and a rat model of the chronic liver disease non-alcoholic steatohepatitis. Rats were subsequently imaged with T2*-weighted magnetic resonance imaging. Results This work demonstrates that the binding of cationized ferritin to the perisinusoidal extracellular matrix is reduced by 55% in a rat model of non-alcoholic steatohepatitis compared to healthy controls. This reduced binding is detectable in vivo with magnetic resonance imaging. Immunofluorescence and electron microscopy indicated that the reduced binding is due to inhibited macromolecular access to the perisinusoidal space caused by non-alcoholic steatohepatitis-related microstructural changes. Conclusions The reduced accumulation of intravenously injected cationized ferritin may report on changes in macromolecular access to the liver parenchyma in chronic liver disease. Magn Reson Med 70:1728-1738, 2013. © 2013 Wiley Periodicals, Inc.

    KW - chronic liver disease

    KW - magnetic resonance imaging

    KW - molecular imaging

    KW - NASH

    UR - http://www.scopus.com/inward/record.url?scp=84887994978&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84887994978&partnerID=8YFLogxK

    U2 - 10.1002/mrm.24619

    DO - 10.1002/mrm.24619

    M3 - Article

    AN - SCOPUS:84887994978

    VL - 70

    SP - 1728

    EP - 1738

    JO - Magnetic Resonance in Medicine

    JF - Magnetic Resonance in Medicine

    SN - 0740-3194

    IS - 6

    ER -